Lista de obras - Federico Pulido - Dominio Público Uruguay

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.

artículo científico publicado en 2014

A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults.

artículo científico publicado en 2004

Acute myelocytic leukemia and human immunodeficiency virus infection

artículo científico publicado en 2001

Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients

artículo científico publicado en 2004

Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy

article

Análisis farmacoeconómico de una estrategia de mantenimiento con lopinavir/ritonavir como monoterapia en pacientes con infección por el VIH

artículo científico publicado en 2006

Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?

artículo científico publicado el 1 de julio de 2010

Cabotegravir and rilpivirine for the treatment of HIV

artículo científico publicado en 2020

Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors

artículo científico publicado en 2008

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.

artículo científico publicado en 2013

Clinical utility of maraviroc.

scientific article published on January 2011

Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).

artículo científico publicado en 2004

Clinico-epidemiological characteristics of HIV-positive immigrants: study of 371 cases

artículo científico publicado en 2012

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

artículo científico publicado en 2015

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

artículo científico publicado en 2014

Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

artículo científico publicado en 2014

Cutaneous lesions in patients with visceral leishmaniasis and HIV infection.

artículo científico publicado en 1997

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

artículo científico publicado en 2010

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

artículo científico publicado en 2009

Definition of advanced age in HIV infection: looking for an age cut-off

artículo científico publicado en 2012

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality

artículo científico publicado en 2009

Detection of Corynebacterium diphtheriae in throat swab specimens from Spanish patients infected with human immunodeficiency virus

artículo científico publicado en 1995

Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy.

artículo científico publicado en 2010

Development of acquired immune deficiency syndrome in a patient with systemic lupus erythematosus

article

Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade

artículo científico publicado en 2013

Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

artículo científico publicado en 2001

Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

artículo científico publicado en 2012

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

artículo científico publicado en 2013

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-in

artículo científico publicado en 2018

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

artículo científico publicado en 2019

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority tri

artículo científico publicado en 2015

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE):

article

Early virologic rebound in a pilot trial of ritonavir-boosted atanazavir as maintenance monotherapy

artículo científico publicado en 2007

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

artículo científico publicado en 2012

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

artículo científico publicado en 2011

Efficacy of fluconazole treatment of candidal endophthalmitis in two heroin addicts

artículo científico publicado el 1 de marzo de 1992

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

artículo científico publicado en 2010

Epidemiological description of the demographic and HIV disease characteristics of HIV patients who are in care but not on treatment in Spain.

artículo científico publicado en 2010

Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results.

artículo científico publicado en 2011

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

artículo científico

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

artículo científico

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

artículo científico publicado en 2016

Factores asociados con la no realización de la prueba de la tuberculina en una cohorte de pacientes VIH positivos

artículo científico publicado en 2009

Factors affecting patient adherence to highly active antiretroviral therapy

artículo científico publicado en 2003

HIV infection in immigrants

artículo científico publicado en 2008

High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).

artículo científico publicado en 2002

How is the implementation of the new legal framework for health care affecting HIV-infected immigrants in an irregular situation in Spain?

artículo científico publicado en 2014

Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.

artículo científico publicado en 2008

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

artículo científico publicado en 2013

Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count

article

Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing

artículo científico publicado en 2014

Inappropriate claim of ‘failure of ritonavir-boosted lopinavir monotherapy in HIV’ in the Monotherapy Switzerland/Thailand (MOST) trial

article

Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

artículo científico publicado en 2003

Incorrect attribution of cerebrospinal fluid HIV-1 virological escape and lymphocytic meningitis to lopinavir/ritonavir monotherapy.

artículo científico publicado en 2010

Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain

artículo científico publicado en 2012

Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus

artículo científico publicado en 1999

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up

artículo científico publicado en 2008

Interpretación y consideraciones metodológicas y estadísticas en los estudios de rescate

artículo científico publicado en 2008

Isoniazid Prophylaxis for High-Risk Patients with Anergy and HIV Infection

artículo científico publicado en 1997

Late acute rejection in renal transplant recipients: response to steroid treatment

artículo científico publicado el 1 de febrero de 1992

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study

artículo científico publicado en 2007

Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption

artículo científico publicado en 2008

Lipid changes in HIV-infected patients who started rescue therapy with an amprenavir/ritonavir-based highly active antiretroviral therapy

article

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors

artículo científico publicado en 2005

Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers

artículo científico publicado en 1998

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

artículo científico publicado en 2008

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks.

artículo científico publicado en 2009

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

artículo científico publicado en 2009

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

artículo científico publicado en 2008

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).

artículo científico publicado en 2005

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

artículo científico publicado en 2008

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses

artículo científico publicado en 2011

Multi-resistant tuberculosis of fatal outcome in a patient without HIV infection

artículo científico publicado el 7 de junio de 1997

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.

artículo científico publicado en 2002

NNRTI hepatotoxicity: efavirenz versus nevirapine

artículo científico publicado el 1 de noviembre de 2002

Necrosis ósea avascular en pacientes con infección por el virus de la inmunodeficiencia humana: un problema emergente

scientific article published on 01 September 2006

Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy

artículo científico publicado en 2013

Neurologic Manifestations of HIV Infection

article

No Evidence for Evolution of Protease Inhibitor Resistance from Standard Genotyping, After Three Years of Treatment with Darunavir/Ritonavir, With or Without Nucleoside Analogues

article

Noninferiority and lopinavir/ritonavir monotherapy trials

artículo científico publicado en 2008

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients

scientific article published on 08 August 2019

Once-daily S/GSK1349572 combination therapy in antiretroviral-naïve adults: rapid and potent 24-week antiviral responses in SPRING-1 (ING112276)

article

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

artículo científico publicado en 2013

Oral ganciclovir as prophylaxis against cytomegalovirus

artículo científico publicado en 1996

Patients' perception and effectiveness of a treatment containing enfuvirtide when used in HIV-infected patients without very advanced disease

artículo científico publicado en 2008

Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008–2010

article

Pharmacokinetics of lopinavir/ritonavir in HIV/hepatitis C virus-coinfected subjects with hepatic impairment

artículo científico publicado en 2006

Predictors of long-term HIV RNA suppression on darunavir/ritonavir monotherapy in the MONET trial

artículo científico publicado en 2013

Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients

artículo científico publicado en 2014

Prevalence of HLA-B*5701 in HIV-infected patients in Spain (results of the EPI Study).

artículo científico publicado en 2009

Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain

artículo científico publicado en 2007

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

artículo científico publicado en 2004

Recomendaciones de GEAM/SPNS sobre el tratamiento de las alteraciones metabólicas y morfológicas en el paciente con infección por VIH

artículo científico publicado en 2006

Recomendaciones españolas sobre el uso adecuado de enfuvirtida

artículo científico publicado en 2007

Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study

artículo científico publicado en 2015

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial

artículo científico publicado en 2008

Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study

artículo científico publicado en 2013

Schwannomatosis, an entity different from neurofibromatosis?

artículo científico publicado el 11 de abril de 1992

Serum (1→3) β‐D‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia in Patients with HIV Infection

article

Signet-ring cell colorectal carcinoma. Study of 2 cases

artículo científico publicado el 1 de junio de 1991

Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy

artículo científico publicado en 2011

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

artículo científico publicado en 2007

Study of the Validity of a Questionnaire to Assess the Adherence to Therapy in Patients Infected by HIV

article

Sustained profile of transmitted drug resistance mutations for more than 10 years in an HIV type 1-infected patient.

artículo científico publicado en 2010

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

artículo científico publicado en 2012

Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.

artículo científico publicado en 2014

Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine

artículo científico publicado en 2013

The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

artículo científico publicado en 2010

The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaría del Plan Nacional sobre el Sida) recommendations for the treatment of tuberculosis in HIV-infected individuals (Updated January 2013)

artículo científico publicado en 2013

The future of antiretroviral therapy: challenges and needs

artículo científico publicado en 2010

The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone

article

Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects

article

Treatment of advanced HIV infection

artículo científico publicado en 2003

Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B

article

Underpowered clinical trials of antiretroviral treatment

artículo científico publicado en 2002

Visceral leishmaniasis as a cause of diarrhoea in HIV-infected patients

article

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study

artículo científico publicado en 2011

[Anti-retroviral treatment. Treatment modification: toxicity management]

scientific article published on 01 October 1996

[Antiretroviral treatment against HIV]

scientific article published on 01 May 1996

Tratamiento antirretroviral de gran actividad administrado una vez al día: ¿presente o futuro? ⬇️

artículo científico publicado el 13 de septiembre de 2003

Lista de obras de Federico Pulido

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.

A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults.

Acute myelocytic leukemia and human immunodeficiency virus infection

Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients

Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy

Análisis farmacoeconómico de una estrategia de mantenimiento con lopinavir/ritonavir como monoterapia en pacientes con infección por el VIH

Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?

Cabotegravir and rilpivirine for the treatment of HIV

Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.

Clinical utility of maraviroc.

Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).

Clinico-epidemiological characteristics of HIV-positive immigrants: study of 371 cases

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

Cutaneous lesions in patients with visceral leishmaniasis and HIV infection.

Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

Definition of advanced age in HIV infection: looking for an age cut-off

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality

Detection of Corynebacterium diphtheriae in throat swab specimens from Spanish patients infected with human immunodeficiency virus

Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy.

Development of acquired immune deficiency syndrome in a patient with systemic lupus erythematosus

Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade

Discontinuation of Secondary Prophylaxis in Patients with Cytomegalovirus Retinitis Who Have Responded to Highly Active Antiretroviral Therapy

Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-in

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority tri

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE):

Early virologic rebound in a pilot trial of ritonavir-boosted atanazavir as maintenance monotherapy

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care

Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis

Efficacy of fluconazole treatment of candidal endophthalmitis in two heroin addicts

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

Epidemiological description of the demographic and HIV disease characteristics of HIV patients who are in care but not on treatment in Spain.

Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

Factores asociados con la no realización de la prueba de la tuberculina en una cohorte de pacientes VIH positivos

Factors affecting patient adherence to highly active antiretroviral therapy

HIV infection in immigrants

High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).

How is the implementation of the new legal framework for health care affecting HIV-infected immigrants in an irregular situation in Spain?

Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions.

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.

Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count

Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing

Inappropriate claim of ‘failure of ritonavir-boosted lopinavir monotherapy in HIV’ in the Monotherapy Switzerland/Thailand (MOST) trial

Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

Incorrect attribution of cerebrospinal fluid HIV-1 virological escape and lymphocytic meningitis to lopinavir/ritonavir monotherapy.

Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain

Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up

Interpretación y consideraciones metodológicas y estadísticas en los estudios de rescate

Isoniazid Prophylaxis for High-Risk Patients with Anergy and HIV Infection

Late acute rejection in renal transplant recipients: response to steroid treatment

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study

Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption

Lipid changes in HIV-infected patients who started rescue therapy with an amprenavir/ritonavir-based highly active antiretroviral therapy

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors

Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers

Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression.

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks.

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.

Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses

Multi-resistant tuberculosis of fatal outcome in a patient without HIV infection

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.

NNRTI hepatotoxicity: efavirenz versus nevirapine

Necrosis ósea avascular en pacientes con infección por el virus de la inmunodeficiencia humana: un problema emergente

Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy

Neurologic Manifestations of HIV Infection

No Evidence for Evolution of Protease Inhibitor Resistance from Standard Genotyping, After Three Years of Treatment with Darunavir/Ritonavir, With or Without Nucleoside Analogues